Dna2 dating

Creepy Talk : The Repository for Inappropriate and Bizarre Messages

2013.07.13 03:38 KrisCraig Creepy Talk : The Repository for Inappropriate and Bizarre Messages

Have you ever received a dick pic on a dating site or a "your hot lets fuck" message from a total stranger on Facebook? Do you enjoy laughing your ass off? Then Creepy Talk is the place for you!
[link]


2019.06.18 10:06 Manaliahire Synthetic Biology Market Size US$ 14 bn by 2026

As per Acumen Research & Consulting, The global synthetic biology market valuation is poised to reach around USD 14 billion by 2026 and will grow at a CAGR above 26.4 % from period 2019 to 2026

Free Download Sample Report Pages for Better [email protected] https://www.acumenresearchandconsulting.com/request-sample/1432

Synthetic biology is one of the world's most rapidly increasing and promising techniques. It applies to a variety of applications in the fields of medicine, agriculture. A powerful company perspective for players in the sector of synthetic biology is likely to be provided by increased financing from government and private institutions. DNA synthesis speed and effectiveness combined with increased genomic information are the main drivers for the use of sophisticated techniques in business product manufacturing, including protein and renewable chemicals. New products are anticipated to be introduced on the market by biofuels, renewable and specialty chemicals manufacturers, by bioproducts, by pharmaceuticals, by health products and by food ingredients.

Companies internationally began to invest in synthetic biology as many government agencies turn to biomass and climate change. In recent years, the industrial interest in synthetic biology has grown and fresh gene editing methods have been a driving force on this market. Genetically engineered goods, DNA sequencing and DNA synthesis techniques replace traditional medications. While this market has a potential, there are risk and obstacles such as public legislation and policies, biological safety and biosecurity concerns, bio-war but legislative bodies and study organizations are addressing these problems. The Synthetic Biology industry has shifted the entire strategy to traditional ways in which sophisticated computing and design systems address new illnesses and genetic difficulties.

View Detail Information with Complete [email protected] https://www.acumenresearchandconsulting.com/synthetic-biology-market

Widening Application Base to Boost Market’s Growth

Thanks to the important rise in its popularity, synthetic biology technology and goods have been used significantly in several fields of implementation. "Based on their use in multiple industrial apps and because the price of studies is reduced, organisms designed for synthetic biology technique are fairly sensible, the demands for this technique are rising significantly in the globe," the analyst for ARC claims. This market will probably be promoted by the increased participation of government agencies, research institutes and large-scale companies in synthetic biology studies in the coming years, the research study notes.

Regional Stance

In the previous few years, Europe has been the world market leader in synthetic biology. This regional market is expected to continue to grow in future years, due to an increase in public involvement and increased financing for the growth of synthetic biology. The increased use of synthetic biology in health, power and the environment is also expected to increase Europe's synthetic biology industry in coming years, the study says. Defence has played a significant role in investing over the previous years in North America. Progress in future trends in Asia, India and China is expected to be part of the market in synthetic biology. The success of this industry depends on the transition from fundamental to apps in which natural biologic systems can be understood in the future. The synthetic biology industry therefore shows no signs of slowness but it leads to innovation to manage future social, ethical and legal liabilities.

Browse all official Market Research Reports Press [email protected] https://www.acumenresearchandconsulting.com/press-releases

Explore Our Market [email protected] https://www.acumenresearchandconsulting.com/blogs

Key Players & Strategies

Due to the existence of big, regional and multinational players on the market the synthetic biology industry is of competitive nature. Amyris, Integrated DNA technologies, DNA2.0, DSM, Evolva, Twist-biotechnologies, Editas Medicine, Inc., GenScript, Novozyme, Pareto Biosyntrox Inc., Blue heron, and Thermo Fischer Scientific were all key industry participants. The firms are adopting approaches such as R&D collaborations, fresh product launches and company expansion joint ventures. Novozymes announced in September 2018 the launch of Balancius, a fresh feed additive that increases the gut's health for broiler chickens. This allows farmers to generate 3% more food from the same feed quantity and move towards more viable manufacturing. This business approach increases the base of customers and reduces the effect on the food production environment.

TABLE OF CONTENTS
CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Synthetic Biology
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Synthetic Biology Market By Product
1.2.2.1. Global Synthetic Biology Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Synthetic Biology Market Revenue Share By Product in 2017
1.2.2.3. Enabled Products
1.2.2.4. Enabling Products
1.2.2.5. Core Products
1.2.3. Synthetic Biology Market By Technology
1.2.3.1. Global Synthetic Biology Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Nucleotide Synthesis & Sequencing
1.2.3.3. Genetic Engineering
1.2.3.4. Bioinformatics
1.2.3.5. Microfluidics
1.2.4. Synthetic Biology Market By Application
1.2.4.1. Global Synthetic Biology Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Pharmaceuticals & Diagnostic
1.2.4.3. R&D
1.2.4.4. Agriculture
1.2.4.5. Chemicals
1.2.4.6. Energy
1.2.5. Synthetic Biology Market by Geography
1.2.5.1. Global Synthetic Biology Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Synthetic Biology Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Synthetic Biology Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Synthetic Biology Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Synthetic Biology Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Synthetic Biology Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Synthetic Biology Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Synthetic Biology Major Manufacturers in 2017
3.3. R&D Status and Technology Product of Global Synthetic Biology Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Synthetic Biology Major Manufacturers in 2017

CHAPTER 4. SYNTHETIC BIOLOGY MARKET BY PRODUCT

4.1. Global Synthetic Biology Revenue By Product
4.2. Enabled Products
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Enabling Products
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Core Products
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY

5.1. Global Synthetic Biology Revenue By Technology
5.2. Nucleotide Synthesis & Sequencing
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Genetic Engineering
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Bioinformatics
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Microfluidics
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. SYNTHETIC BIOLOGY MARKET BY APPLICATION

6.1. Global Synthetic Biology Revenue By Application
6.2. Pharmaceuticals & Diagnostic
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. R&D
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Agriculture
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Chemicals
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Energy
6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY COUNTRY

7.1. North America Synthetic Biology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Synthetic Biology Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Synthetic Biology Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE SYNTHETIC BIOLOGY MARKET BY COUNTRY

8.1. Europe Synthetic Biology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Synthetic Biology Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC Synthetic Biology MARKET BY COUNTRY

9.1. Asia-Pacific Synthetic Biology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Synthetic Biology Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA SYNTHETIC BIOLOGY MARKET BY COUNTRY

10.1. Latin America Synthetic Biology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Synthetic Biology Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST SYNTHETIC BIOLOGY MARKET BY COUNTRY

11.1. Middle East Synthetic Biology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Synthetic Biology Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA SYNTHETIC BIOLOGY MARKET BY COUNTRY

12.1. Africa Synthetic Biology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Synthetic Biology Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Amyris
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Integrated DNA technologies
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. DSM
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Evolva
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Twist biosciences
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Editas Medicine, Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. GenScript
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Novozyme
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Pareto Biotechnologies
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Blue heron
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Thermo Fischer Scientific
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Others
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Type Portfolio
13.12.5. Key Developments
13.12.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope




Request for [email protected] https://www.acumenresearchandconsulting.com/request-customization/1432

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report - https://www.acumenresearchandconsulting.com/buy-now/0/1432

If you would like to place an order or have any questions, please feel free to contact at [[email protected]](mailto:[email protected]) +1 407 915 4157


About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
submitted by Manaliahire to u/Manaliahire [link] [comments]


2018.05.02 19:58 LiterallyUnlimited Wait, what's wrong with my phone? (My complete guide to understanding SKUs and ownership on Sprint)

When activating a phone on Sprint, you may get denied for a number of reasons. Some I can help with, some I can't, as part of my role working for /ting. This is as exhaustive of a list as I can make of what the problems might be.
[A] Phone Ownership Flag 
Sprint maintains a device database that includes everything they'll activate on their network. Included in this database are things like frequencies, what SIM card you need and something called a Phone Ownership Code. This is sometimes referred to as PoC, or, more commonly by its positions, SPCS and PLBL. You can read more about that here. At a store level, this is sometimes called "Item ID not compatible with brand."
If the flag is set to PLBL, Sprint won't activate it on Sprint Postpaid.
*** How to fix it: ***
Sprint tech support can flip the ownership flag, as can the last MVNO where the device was active. So, if your PLBL phone was last active on Tello, contact Tello tech support to flip the ownership flag.
If you're going through Sprint Tech support you'll want to have them file a ClickIT ticket. If you're going through an MVNO, this should be easily accomplished by their regular support team, as moving the phone from SPCS to PLBL in the first place is step 1 in making a Sprint phone compatible with an MVNO.
** The MVNOs do have the tools to fix this **. It's part of the wholesale API that Sprint gives them access to. Press them on the issue if they insist they don't. Any MVNO worth their salt should be able to verify the ownership flag position and change it.
[B] Phone not in database 
This error typically means the phone either is completely incompatible with Sprint (as it's not in the database) or it's one of the very few devices that is compatible, and just needs to be added.
If this is an iPhone, contact a Sprint store or tech support and have them add the phone via DNA2. This process shouldn't take more than a few minutes at most, and once added the phone should be able to be activated instantly.
Rare: If your iPhone has an Activation Policy from a non-US carrier and is unlocked, Sprint's DNA2 tool will not add the phone, despite it being otherwise compatible. No, I don't know why they did this, and no I don't think there's a workaround. Sprint made their decision to refuse iPhones with initial foreign activation policies.
If your phone is not an iPhone, you'll need Sprint tech support to file a ClickIT ticket to add the device to the database. The proper ticket they need to file is called "ESN Not Loaded". Here's a Reddit write-up I did about it back when I worked for Sprint.
Not all phones will be able to be added via ClickIT, and if your ticket is denied, you should probably accept that the phone will not work on Sprint.
[C] Phone SKUs 
In Sprint's database, every phone has a SKU that identifies the manufacturer, model, color and in some cases capacity. For example, a Nexus 5X has a SKU of LGH79016KT1, with its name in the database as LG H790 16GB XCVR SGL. I typically use the second entry as 'SKU' when I talk about it, even though the SKU is technically the first one.
This tells us a lot about this device in Sprint's database. It's an H790 made by LG, 16GB storage capacity. Similarly, an iPhone could be IPH5C16GWH1 or IPHONE 5C WHITE 16GB SGL. From this, we can see it's an Apple iPhone 5C 16GB in White.
BUT. Some phones have their SKUs changed when they're used on different networks. Boost Mobile and Virgin Mobile are notorious for changing the SKU on devices while in the Sprint database, and there are two possible outcomes when you've got a SKU that Sprint won't activate.
[C1] Phones reSKUed by BYOD checkers 
This happens when you have used the Virgin Mobile USA or Boost Mobile BYOD checker to see if your phone is compatible with their network. In order to make the phones eligible for the network, the phones SKUs are changed in the database. This is most-common with iPhones, but has happened to other devices. My iPhone has the SKU BYOFD ISE GRY 128 VMU SGL. See the VMU in the middle? That means I used my phone's IMEI in Virgin Mobile's BYOD checker, and the SKU of my phone has been changed. It's now not compatible with Sprint postpaid as a result
Phones SKUed this way can be activated on their SKUed brand (VMU, in my case) and on MVNOs like Ting.
** How to fix it **
Sprint will not activate these phones on Postpaid until they've undergone a 'reSKU' by tech support (888.211.4727). A technician will assess your phone, and change the SKU back to something compatible with Sprint Postpaid, without the VMU or BST branding.
Update: If you have an iPhone, you may be able to re-SKU the device yourself.
[C2] Phones with SPP, BST and VMU SKUs out of the box 
These are phones that are branded with Boost Mobile, Virgin Mobile or Sprint Prepaid out of the box. These phones were designed to only ever be used with these brands. Sprint will not activate them, even if the phone ownership flag [A] is set to the right position.
These phones were typically sold at a discounted rate with the understanding that they would be only ever used on that prepaid brand. These phones can sometimes be used on MVNOs like Ting, once financial eligibility has been met. See Financial Eligibility [D] later in this document.
Tech support will not reSKU these devices, and you're unlikely to ever be able to activate them on Sprint Postpaid. You're better off keeping these devices to their marked brands or MVNOs that give the thumbs-up.
[D] Financial Eligibility, or FED 
Books have been written about FED both on /sprint and /ting, so I'm not going to re-hash over those.
All you need to know about FED is that Sprint has a FED flag, the Financial Eligibility Date flag with a date that usually coincides with when the phone was paid off.
If that date is in the future, the device has not reached financial eligibility. If you can find someone with access to the actual date, sometimes these phones spit back a date in 2099, which is the most common indicator that a phone has not been paid off yet.
These phones can't be activated on MVNOs, and Sprint is unlikely to let you use one of these devices on Sprint Postpaid in some instances. YMMV on that.
If your FED date is in the past, you will not get any error messages about this.
I'll update this post as needed. [Last updated 19 December, 2018]
submitted by LiterallyUnlimited to LiterallyUnlimited [link] [comments]


2016.06.06 19:04 LiterallyUnlimited Coming 6/10/2016: Sprint BYOD SIM kits

Ask and ye shall receive.
Launch date is 06/10/2016.
The BYOD SIM kit is a 3-in-1 muti-punch UICC card that separates into three different sized UICC SIM Cards.
The SIM KIT was designed to specifically support BYOD capable devices. It is NOT a replacement for the Primary UICC Card for a device but rather a supplementary universal UICC card certified to work on BYOD capable handsets.
This is big news for those BYOD customers who want to activate but may have issues finding the right SIM at their local store.
There are some caveats. While there is a $0 charge for the kits, customers are still required to authenticate prior to ordering. This means these are intended for Sprint customers only, and not for resellers like Ting or RingPlus.
The SKU for the kit is 76049203450.
The kits are intended to be sold at Sprint stores and dealers, as well as Telesales. Business channels will not be participating, and can order SIM cards as they currently do.
If your local store does not have them in stock on launch, ask if they can place a Direct Ship order for it to be shipped to that store or your billing address. The bonus to having it shipped to the store is you don't need to be home to pick up the UPS delivery. An adult will sign for it and it will be held for you till you can pick it up.
At launch, capable devices include
Apple iPad Air, Air 2, mini 3, mini 4
Apple iPad PRO 12.9, 9.7
Apple iPhone 5C (VZW only)
Apple iPhone 5S (VZW only)
Apple iPhone 6/6+/6S/6S+
Apple iPhone SE
Huawei Nexus 6P
LG Nexus 5
LG Nexus 5X
Motorola Nexus 6
Motorola Moto X Pure
Every time we talk about BYOD, I get a few dozen OrangeReds about DNA2 and adding phones to the database. For clarification, only iPhones from other carriers can be put through DNA2, and even then only if they're on the list above. Your Verizon 4S cannot be added to DNA2 and will not work on Sprint, and I'm not going to try it just so you can get it on RingPlus. Talk to RingPlus about that.
submitted by LiterallyUnlimited to Sprint [link] [comments]


2016.01.07 22:38 troll413 Thoughts on UHC Seasons best to worst?

K so I am kind of bored and I decided it would be cool if I gave a list of all of the UHC Seasons from worst to best (IN MY OPINION). Keep in mind Mindcrack UHC is a great series so having a "bad" season isn't normally a thing for this group and on average I love the series
23rd: Season 16. Holy cow this one sucked. I know that the Mindcrack UHC isn't scripted and it isn't their faults but there were no interesting battles, it was 1.8, the best commentary team was eliminated in episode 3, and worst of all there were no PvE deaths. Ultra Hardcore is about watching people try to survive their environment with only 10 hearts. If we wanted to watch people shoot arrows and swing swords we could watch Huahwi do Hunger Games. Avoid this season. 2/10
22nd: Season 14. Again, Mindcrack UHC has a very high standard of quality, so an average season like this can en up at 22nd. This season was OK, but Pause did kinda dominate the entire time and the outcome really was predictable. Enjoyable season though. 5/10
21st: Season 15. This season had bright spots, like BTC's teaching the haters a lesson about his PvP skills and the beginning of the Age of Justice. I have to say though, nothing happened in episodes 4-7. 5/10
20th: Season 13. Controversy! This was a polarizing season, with comments ranging from, "Season 13 is the lord and savior" to "This season was ruined for me, just kill it with fire." I liked season 13, Team BAND had a great POV and OMW was, indeed, hilarious. But as a BTC fan this season was heartbreaking. I love BTC and I was so disappointed by his performance in this season. Also 1 PvE death. Still, I have fond thoughts on Season 13. High 6/10
19th: Season 20. Wow, how can a Dragon season be 19th? The answer: because Mindcrack UHC has great seasons. This season has excellent commentary from everyone but Leftovers (IMO IMO THIS IS JUST MUY OPINION) and was very dramatic until the end. Plus BTC won again. So why is it not higher? Well, it's hard to say. Part of it is the No PvE death part, that disappointed me. But more importantly, the deaths just had such a weird structure. 6 in episode 5, 8 in episode 8, and one other. Also Mega Tiagas are ugly. 7/10
18th: Season 18 (LOL). This season was a bit dry i suppose as far as good battles go, however Chad's portal escape was nothing short of epic and team PWN had great commentary. And the egg incident was hilarious. 7/10
17th: Season 7. This is a popular one, but honestly I think the final battle was kinda lame as JustDefy ran into a chuck error. Guess that's what happens when you team with Nebris! I really just don't have much to say about this one. 7/10
16th: Season 10. Another season with 1 PvE death. This season felt really dragged out. But honestly both of those issues are redeemed by Pause's perspective, with one of the most intense battles with survival (and MCGamer's fists!) and then the most epic clutch against Team Uppercat. Honestly i could watch that over and over again. Ding Ding Ding Ding 7/10
15th: Season 21. This was a very solid season. I might be a bit too high because I love ice spikes biomes and I think they are pretty, but the dynamic of the teams and the really intense episode 7, wow that was one of the most insane episodes ever. Also I know there were no PvE deaths but I can forget about that when I watch VintageBeef do episode 4. 7/10
14th: Season 5. So observant readers may have noticed that I haven't put an FFA season here yet. I love FFA seasons much more than team ones, that's just me. And Season 5 is no exception, a classic season with Etho's Doc stalking kill and Baj's underwater house. But that Kurt death though, that was so sad and unfair, and I can't give this season any higher than 7/10 because of it.
13th: Season 4. Not as good as 4b. "Get to the damn land man." was funny. Very close final battle, but again, Beef's enderman glitch and I have to settle for a 7/10 here.
We're in the top half now, these seasons are the ones that are truly fantastic. 12th: Season 2. This is a weird one, one of those two "Nancy Drew kills the Dragon" seasons, and it is very good. Of course, 14 episodes is a taxing watch and I always think it is kind of lame when 3/4 of a team wins (Hurts S20 too) but still watching these people set up their base and survive the wilderness against all odds is amazing. 8/10
11th: Season 8. This was a great season. Would have been higher but it was 5 episodes. Still though, Etho's triple kill, BDubs and Millbee's early clash, the hilarious season of generikb. Not too much more to say. 8/10
10th: Season 12. This season was very glitchy so I really shouldn't like it, but honestly this season featured the most epic struggle to survive yet. although it sucks that Avidya had to die, we still got the final 8 players all on less than 6 hearts fighting for their lives against a hostile wilderness. Definitely recommended except for the rushed finale. 8/10
9th: Season 17. This season had weird caves and Nebris was very predictable as a winner, but let not that detract from this season's glorious Justice. I could talk about Bdubs's epic battle with survival, or Anderz's potion rush, or about BTC's hilarious ragey commentary that time, however this season was the Season of Justice, and should be solely acknowledged as such. 8/10
8th: Season 4b. I am SO glad they redid season 4 because we got this. Hilarious commentary all about, much more active acquiring of gear and no episode 1 deaths, and a classic, still-referenced to this date finale that for me goes down as one of the best in UHC history, even better than season 4. 8/10
7th: Season 1. The first every season of UHC. Honestly hilarious watching this and looking at their strategies. 9/10
6th: Season 19. LOL! The other season of controversy is here, except for this time this season is nothing but a massive ball of awesome. What pushes this season over the edge is the unlikeliness of the winning team. Ever episode it just seemed to get worse and worse for purple and then they won in the most glorious fashion possible. And it was Vechs and BTC, my 1st and 2nd favorite Mindcrackers in that season. Oh, and on the aqua end you have to watch Oculus Rift MC do Episode 4. I could not have scripted a more dramatic season myself. 9/10
5th: Season 22. The newest installment in UHC, and a great one at that, mostly because of two reasons. The first being that it was in 1.2, when UHC reached its summit and certainly provided epic PvE experiences with Kelley Blue Book and DNA2 and Survivor. The second: Team Sechsy Chad. This was a perfect team, all being alive at the win (the first time this has happened in teams of 3) and having an epic and tense nether adventure. And their commentary was great. I honestly love Vechs's UHC perspectives. 9/10
4th: Season 6. Why is this season not remembered as a true classic? Everythinig about this was perfect except for Justdefy's death which is why this gets a 9/10. But Anderz's and Zisteau's battles with survival, Kurt's hilarious POV (Cobwebs), MCgamer's victory scream, and the Pause and Nebris double kill. Amazing.
3rd: Season 9. These top 3 are flawless. What can I even say here? It's Season 9. Literally every team had top-notch commentary and there were so many shining moments. Nancy Drew's comeback victory, Fairly Hardcore's unexpected portal light, MC's comeback to 9 hearts, Potty Mouth's apple chugging, Kurt's not needing to apple chug. This was amazing.
2nd: Season 11. This season was soooo cool. Every had an interesting perspective who made like the top 10 and there were so many highlight moments. The Bdubs/Kurt fight, Baj Grylls returning for a truly absurd performance, the adventures of Millbee and his reaction at getting a kill, Pause and Zisteau and Shree's derpy deahts. But what makes this season so amazing is the dynamic that occurred in the final 6. Everyone except Anderz had some sort of advantage which they could use to win. (A fire sword, OP enchants, potions, 40 dogs, and a skybase.) This led to the best episode in UHC history. I suppose BTC didn't win in the best way possible (by killing Etho with a sword in 6 seconds, was a bit anticlimactic.) but the fact that he won amidst the overpowered season that looked like it was stacking up to be Season 8 - Part 2 from Etho is astonishing, especially while taking 4 hearts of damage throughout the entire time only. 10/10
1st: Season 3. Pretto obvious. I think everyone loves season 3 the most, and for good reason. First of all: Baj Grylls probably had the most enjoyable POV in UHC history. But more importantly, it was just amazing seeing all of these people struggle to stay alive all on very low health except Guude. Nobody knew how to play UHC solo, so they all had to figure out and figure out quickly (especially beef.) It was an amazing experience watching Season 3, and I don't think it is possible to ever have a better season. 10/10
Leave your thoughts on the Best UHC seasons below. And be respectful please, as opinions are not worth getting angry over.
submitted by troll413 to mindcrack [link] [comments]